NANOABLATION is a Hangzhou company developing pulsed electric field systems for tumor treatment and related medical devices.
Founded in 2014 and based in Hangzhou, China, NANOABLATION develops pulsed electric field technology for tumor treatment, including a nanosecond pulse tumor ablation system and minimally invasive puncture electrodes. The company holds ISO13485 certification and has applied for nearly 200 patents. It closed a Series B+ round in February 2025 to advance clinical trials and commercialization of products built on its nanosecond pulsed electric field platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in